Načítá se...
Stem cells and regenerative therapies for Parkinson’s disease
Currently the mainstay of Parkinson’s disease (PD) therapy is the pharmacological replacement of the loss of the dopaminergic nigrostriatal pathway using drugs such as dopamine agonists and levodopa. Whilst these drugs effectively ameliorate some of the motor features of PD, they do not improve many...
Uloženo v:
| Vydáno v: | Degener Neurol Neuromuscul Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065567/ https://ncbi.nlm.nih.gov/pubmed/30890881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S16087 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|